Rationale and design of the balANZ trial: A randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function-Reference-Cited by-同舟云学术

Rationale and design of the balANZ trial: A randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function

Published:2010-09-16 Issue:1 Volume:11 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Johnson David W,Clarke Margaret,Wilson Vanessa,Woods Feidhlim,Brown Fiona G

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/article/10.1186/1471-2369-11-25/fulltext.html

Reference33 articles.

1. Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK: Continuous ambulatory peritoneal dialysis. Ann Intern Med. 1978, 88: 449-456.

2. Krediet RT: 30 years of peritoneal dialysis development: the past and the future. Perit Dial Int. 2007, 27 (Suppl 2): S35-S41.

3. Serkes KD, Blagg CR, Nolph KD, Vonesh EF, Shapiro F: Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: a multicenter study. Perit Dial Int. 1990, 10: 15-19.

4. Vonesh EF, Moran J: Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1999, 10: 354-365.

5. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, Jeffery JR, Kjellstrand CM: Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates [see comments]. Am J Kidney Dis. 1997, 30: 334-342. 10.1016/S0272-6386(97)90276-6.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Incremental peritoneal dialysis with residual kidney function decline in patients on peritoneal dialysis: The balANZ trial;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2023-05-31

2. Utility of serum beta-trace protein as a tool for estimating residual kidney function in peritoneal dialysis patients;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2020-08-20

3. Biocompatible dialysis fluids for peritoneal dialysis;Cochrane Database of Systematic Reviews;2018-10-26

4. Associations between Peritoneal Glucose Exposure, Glucose Degradation Product Exposure, and Peritoneal Membrane Transport Characteristics in Peritoneal Dialysis Patients: Secondary Analysis of the balANZ Trial;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2018-09

5. Kinetic Modeling and Adequacy in PD;The Essentials of Clinical Dialysis;2017-08-18